Epidemiology of cancer pain and factors influencing poor pain control.
about
Oxcarbazepine for neuropathic painOxcarbazepine for neuropathic painNeuropathic pain: a practical guide for the clinicianBreakthrough cancer pain: review of prevalence, characteristics and managementAn evidence-based algorithm for the treatment of neuropathic painEncountering a Neglected Area of a Healthcare System: A Decade of Improvement in Cancer Pain Clinical Practice in IranTendency to adhere to provider-recommended treatments and subsequent pain severity among individuals with cancerInside preview of procuring narcotic license.Perspectives, perceptions and experiences in postoperative pain management in developing countries: A focus group study conducted in Rwanda.Methadone for cancer pain: what have we learned from clinical studies?A review of opioid prescription in a teaching hospital in Colombia.Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer.Evaluation of knowledge of cancer pain management among medical practitioners in a low-resource settingAn Epidemiological Study of Neuropathic Pain Symptoms in Canadian Adults.Patient empowerment in cancer pain management: an integrative literature review.Advantages of an etiology-based method for treating cancer pain: a case report and literature review.Pharmacological Management of Cancer-Related Pain.Patient and caregiver perspectives on managing pain in advanced cancer: A qualitative longitudinal study.Attitudes of medical oncologists in Qatar toward palliative care.A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels.Review of Opioid Pharmacogenetics and Considerations for Pain Management.Perspectives of Health Care Providers on US South Asians' Attitudes Toward Pain Management at End of Life.The Impact of a National Guideline on the Management of Cancer Pain on the Practice of Pain Assessment and Registration.Comparison of antinociceptive effect of the antiepileptic drug gabapentin to that of various dosage combinations of gabapentin with lamotrigine and topiramate in mice and rats.Postherpetic neuralgia, diabetic neuropathy, and trigeminal neuralgia - Chronic peripheral neuropathic pain in 58,480 rural Italian primary care patients.Physicians' self-assessment of cancer pain treatment skills--more training required.The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.Flying blind: sources of distress for family caregivers of palliative cancer patients managing pain at home.Pain is not systematically registered in Dutch medical oncology outpatients.Oxcarbazepine for neuropathic pain.Adaptation of an evidence-based clinical practice guideline in cancer pain management by medical oncologists: a case vignette study.A modern analgesics pain 'pyramid'.Evidence-based practice for pain management for cancer patients in an acute care setting.
P2860
Q24198916-2E1C3E88-249E-487D-AB0D-E719F5A3DC79Q24240708-7C3D1954-CE10-4B3C-83FB-D59A623C9377Q24553796-72C9E89E-F51D-4714-8189-DC833209899BQ24633771-659360FA-BDFD-403F-8508-8C221672CE81Q24680820-B3CD8692-7FF0-4D11-8295-3603E8936D54Q30489700-9B4381DC-18E3-4D13-A9F3-C936683468CEQ34554883-B6DF887B-E4D5-4AB4-9FE3-908F91FDD7D4Q35785157-F8D744C9-D25D-4D12-A9AD-7ED9FC14B389Q36132144-90424E8C-06AE-4A64-BF6F-5F1B63801FAEQ36135137-39A9B625-9294-49D1-B81E-811F9031F8ADQ36235096-6B64DA52-096C-4033-9CF2-DBA245A55926Q36368292-2F36911C-C2F5-4EE9-9B1C-509020A9537CQ36601378-CD2EFA19-631D-4928-8785-7AB9A597141DQ36996908-B439CD22-885F-458E-B3C9-BC474121B72CQ38210905-A3052B9E-511D-4252-AA1B-98479CBD19F9Q38556697-A6CAE16A-2589-478A-B70C-35E4F2AC3951Q38672359-17CA8D70-804B-4975-BC7C-54CE1F082D26Q38723667-1EAB2B50-36D6-4CD0-A6D6-DA17533E165AQ39241068-C80A7489-2C1C-484F-8602-0EE02A327D2AQ39268834-8E224C21-A887-4F07-A832-97B035658B79Q39430407-1D6C5DC0-AC56-4DB4-B58F-AAB6E45E53A8Q41131738-A90B98BB-A7B0-4107-A50E-0847DB0ED64EQ41642535-4F867AA7-8D7A-4C1C-8FA3-97FDA9891A83Q42064160-7E8CB6B9-354B-461A-9D51-D50E10751E84Q42276128-1050FE7A-CD1E-43A2-A2DB-5D0655239AA8Q42635753-6292AFEA-B156-423A-89E1-FD23289E9CB3Q43243208-BB246DFE-CCC0-4FE9-ADB7-6AC5CD6B4039Q43512817-16B23224-B719-4E9D-AC57-6AD4621EAE8CQ44939612-DFEDC946-9827-40C0-8DCD-4508F2878C83Q47376802-4A64A470-55CA-4F97-94F4-099CB7D81F3EQ48018250-7A2D1137-D744-49CA-8DA3-5B8406071154Q51127111-535A34E1-EFF1-42E8-9ABF-F2FC892E74BAQ53312682-CB562CE4-9C83-4C39-AE9A-C164148E152A
P2860
Epidemiology of cancer pain and factors influencing poor pain control.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Epidemiology of cancer pain and factors influencing poor pain control.
@ast
Epidemiology of cancer pain and factors influencing poor pain control.
@en
type
label
Epidemiology of cancer pain and factors influencing poor pain control.
@ast
Epidemiology of cancer pain and factors influencing poor pain control.
@en
prefLabel
Epidemiology of cancer pain and factors influencing poor pain control.
@ast
Epidemiology of cancer pain and factors influencing poor pain control.
@en
P2860
P1476
Epidemiology of cancer pain and factors influencing poor pain control.
@en
P2093
Declan Walsh
Mellar P Davis
P2860
P304
P356
10.1177/104990910402100213
P577
2004-03-01T00:00:00Z